Markets:

Overview

News

Currencies

International

Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Catalent, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

What 9 Analyst Ratings Have To Say About Catalent ↗

November 16, 2023

Via Benzinga

Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy ↗

November 15, 2023

Catalent Inc's (NYSE: CTLT) Q1 FY24 revenue of $982 million decreased 4% as reported, or 6%, in constant currency, beating the

Via Benzinga

Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday ↗

November 15, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported...

Via Benzinga

Topics Earnings Stocks

US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking? ↗

November 15, 2023

U.S. stocks could build on the momentum they picked up on Tuesday following the release of benign inflation data. Traders get to digest another batch of economic data on producer price inflation,...

Via Benzinga

Topics Economy

Recap: Catalent Q1 Earnings ↗

November 15, 2023

Via Benzinga

Preview: Catalent's Earnings ↗

November 14, 2023

Via Benzinga

Analyst Ratings for Catalent ↗

September 29, 2023

Via Benzinga

BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake ↗

November 07, 2023

The company's recently FDA-approved gene therapy is struggling to gain traction.

Via Investor's Business Daily

What's Going On With Biotech Contract Service Firm Catalent Stock Today? ↗

October 31, 2023

Catalent Inc (NYSE: CTLT) shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc (NASDAQ: SRPT) on the back of disappointing data from a pivotal gene therapy trial.

Via Benzinga

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

15 Analysts Have This to Say About Catalent ↗

August 31, 2023

Via Benzinga

Catalent Earnings Preview ↗

August 28, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 31, 2023

It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 30, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 19, 2023

Via Benzinga

Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market ↗

October 09, 2023

Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)...

Via Benzinga

3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late ↗

September 07, 2023

With debt getting more expensive, it’s become easier to recommend unloading these three S&P 500 stocks now.

Via InvestorPlace

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny ↗

September 02, 2023

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

Via Benzinga

Why Catalent Stock Zoomed 12% Higher This Week ↗

September 01, 2023

A strong earnings report and a clutch of analyst price target hikes will do that.

Via The Motley Fool

Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says ↗

August 30, 2023

Tuesday, Catalent Inc (NYSE: CTLT) reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the

Via Benzinga

RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know ↗

August 30, 2023

Via Benzinga

Why Catalent Stock Surged Nearly 5% Higher Today ↗

August 29, 2023

Fourth-quarter performance that wasn't too disappointing, plus a settlement with an activist investor, brought some bulls back to the company's shares.

Via The Motley Fool

Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count ↗

August 29, 2023

Workhorse (WKHS) stock is on the move Tuesday after the company failed to get shareholder approval to increase its share count.

Via InvestorPlace

Can a New CFO Save Canoo (GOEV) Stock? ↗

August 29, 2023

Canoo (GOEV) stock is getting a boost on Tuesday as investors react to the company naming its new Chief Financial Officer.

Via InvestorPlace

ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%? ↗

August 29, 2023

Oracle (ORCL) stock is in the news Tuesday as UBS analyst Karl Keirstead makes a bull case for the information technology company's shares.

Via InvestorPlace

Topics Artificial Intelligence

China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories ↗

August 29, 2023

Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm

Via Benzinga

Topics Artificial Intelligence Economy

Catalent (CTLT) Stock Gains on Elliott Deal ↗

August 29, 2023

Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management.

Via InvestorPlace

Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings ↗

August 29, 2023

Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.

Via Benzinga

Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles ↗

August 25, 2023

Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Catalent, Inc. Common Stock (NY:CTLT)

Headline News about Catalent, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today